Acute hepatitis B with delta-agent
ICD-10 B17.1 is a billable code used to indicate a diagnosis of acute hepatitis b with delta-agent.
Acute hepatitis B with delta-agent is a viral infection caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV), which is a defective virus that requires HBV for its replication. This condition is characterized by an acute onset of symptoms such as jaundice, fatigue, abdominal pain, and elevated liver enzymes. The delta agent can exacerbate the severity of hepatitis B, leading to a higher risk of fulminant hepatitis and chronic liver disease. Transmission occurs primarily through blood and bodily fluids, including sexual contact and sharing of needles. Acute hepatitis B with delta-agent can lead to significant liver complications, including cirrhosis and hepatocellular carcinoma, particularly in individuals who progress to chronic infection. Management involves monitoring liver function, providing supportive care, and in some cases, antiviral therapy. Understanding the interplay between HBV and HDV is crucial for effective treatment and management of patients with this condition.
Detailed patient history, laboratory results, and treatment plans.
Diagnosis of acute hepatitis in patients with risk factors such as IV drug use or unprotected sex.
Need for comprehensive documentation of co-infections and treatment response.
Liver function tests, imaging studies, and biopsy results if applicable.
Management of patients with acute hepatitis presenting with severe symptoms.
Documentation of liver complications and ongoing management strategies.
Used to confirm the diagnosis of hepatitis B.
Document the reason for testing and results.
Infectious disease specialists may require additional serological tests.
Acute hepatitis B is caused solely by the hepatitis B virus, while acute hepatitis B with delta-agent involves co-infection with the hepatitis D virus, which can lead to more severe liver disease.
